Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Roth MKM Keeps Their Buy Rating on HEALWELL AI (AIDX)

Tipranks - Tipranks - Fri Feb 13, 2:58PM CST

Roth MKM analyst Kyle Bauser reiterated a Buy rating on HEALWELL AI today and set a price target of C$2.50.

Valentine's Day Sale - 70% Off

According to TipRanks, Bauser is an analyst with an average return of -12.4% and a 37.86% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Electromed, HeartBeam, and Apyx Medical.

In addition to Roth MKM, HEALWELL AI also received a Buy from Scotiabank’s Kevin Krishnaratne in a report issued on February 4. However, on the same day, TipRanks – Google reiterated a Hold rating on HEALWELL AI (TSX: AIDX).

See today’s best-performing stocks on TipRanks >>

Based on HEALWELL AI’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of C$30.35 million and a GAAP net loss of C$27.86 million. In comparison, last year the company earned a revenue of C$13.74 million and had a GAAP net loss of C$10.57 million

Read More on TSE:AIDX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).